Paper41659632
Coupling high-throughput protease enzymology with viral replication reveals biochemical constraints of viral fitness.
Aidlen D and 14 others. bioRxiv, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Coupling high-throughput protease enzymology with viral replication reveals biochemical constraints of viral fitness. Papers, record 41659632. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41659632
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Coupling high-throughput protease enzymology with viral replication reveals biochemical constraints of viral fitness.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DP5 OD033413 | NIH HHS | United States | DP5OD033413 | PubMed | NIH RePORTER |
| T32 GM145460 | NIGMS NIH HHS | United States | T32GM145460 | PubMed | NIH RePORTER |
| U19 AI171110 | NIAID NIH HHS | United States | U19AI171110 | PubMed | NIH RePORTER |
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15116359 | Development and testing of a general amber force field. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15116359 | PubMed |
| 2 | 40267184 | Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy. | Sci Adv | 2025 | https://conductscience.org/library/papers/40267184 | PubMed |
| 3 | 33602850 | Phage-assisted evolution of botulinum neurotoxin proteases with reprogrammed specificity. | Science | 2021 | https://conductscience.org/library/papers/33602850 | PubMed |
| 4 | 21959240 | Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates. | Nat Protoc | 2011 | https://conductscience.org/library/papers/21959240 | PubMed |
| 5 | 36351451 | Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. | Nature | 2023 | https://conductscience.org/library/papers/36351451 | PubMed |
| 6 | 35723575 | Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms. | Elife | 2022 | https://conductscience.org/library/papers/35723575 | PubMed |
| 7 | 29695431 | Timeliness of Proteolytic Events Is Prerequisite for Efficient Functioning of the Alphaviral Replicase. | J Virol | 2018 | https://conductscience.org/library/papers/29695431 | PubMed |
| 8 | 29038472 | Phage-assisted continuous evolution of proteases with altered substrate specificity. | Nat Commun | 2017 | https://conductscience.org/library/papers/29038472 | PubMed |
| 9 | 39673710 | SARS-CoV-2 3CLpro (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CLpro. | Cell Rep | 2024 | https://conductscience.org/library/papers/39673710 | PubMed |
| 10 | 12475199 | Serine protease mechanism and specificity. | Chem Rev | 2002 | https://conductscience.org/library/papers/12475199 | PubMed |
| 11 | 35217718 | Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay. | Commun Biol | 2022 | https://conductscience.org/library/papers/35217718 | PubMed |
| 12 | 8744570 | VMD: visual molecular dynamics. | J Mol Graph | 1996 | https://conductscience.org/library/papers/8744570 | PubMed |
| 13 | 15264254 | UCSF Chimera--a visualization system for exploratory research and analysis. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15264254 | PubMed |
| 14 | 36829241 | DIMPLE: deep insertion, deletion, and missense mutation libraries for exploring protein variation in evolution, disease, and biology. | Genome Biol | 2023 | https://conductscience.org/library/papers/36829241 | PubMed |
| 15 | 19351898 | Dynamical networks in tRNA:protein complexes. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19351898 | PubMed |
| 16 | 28933778 | Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity. | Nat Protoc | 2017 | https://conductscience.org/library/papers/28933778 | PubMed |
| 17 | 21406063 | Proteases as therapeutics. | Biochem J | 2011 | https://conductscience.org/library/papers/21406063 | PubMed |
| 18 | 16955069 | Targeting proteases: successes, failures and future prospects. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/16955069 | PubMed |
| 19 | 33460213 | What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design. | Med Res Rev | 2021 | https://conductscience.org/library/papers/33460213 | PubMed |
| 20 | 21604128 | Protease specificity profiling by tandem mass spectrometry using proteome-derived peptide libraries. | Methods Mol Biol | 2011 | https://conductscience.org/library/papers/21604128 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MAP2K7 | 5609 | PubTator's text mining | https://conductscience.org/library/genes/5609 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41659632
GET https://conductscience.org/api/papers/v1/41659632/references?page=2